Pharmaceutical & Healthcare | Kisaco Research

Pharmaceutical & Healthcare

Register for an event
Register for an event
Sponsor an Event
Sponsor an Event
Who’s Involved
Who’s Involved
Filter by:
 
Rare Disease Diagnostics Summit
24-25 Sep 2019
Boston, MA
The diagnostic component of genetic rare diseases must be addressed. More than 350 million people are living with a rare disease. On average it takes 7 different consultations before an initial referral to a clinical geneticist and a minimum of 5 years to completely diagnose a patient, with 70-90% of cases going undiagnosed. With roughly 7,000 known rare diseases, 80% have a genetic crisis.The numbers are clear, and it’s time to act now.This event will bring together drug companies, patient advocacies, diagnostic providers, insurance companies, and other key stakeholders to facilitate earlier and better diagnosis of rare genetic diseases.This event will enable partnerships between diagnostic and pharma companies for companion diagnostics, provide a platform for industry to build the much-needed relationships with patient advocacies, and facilitate knowledge-sharing on genetic discovery, biomarkers, disease mechanisms, and novel strategies to improve early rare genetic disease diagnosis.
 
Protein Degradation Congress Asia
6-7 Nov 2019
Hong Kong
“Targeted protein degradation promises to be the greatest innovation in small molecule drug discovery in the new millennium.” - Manfred Koegl, Lab Head Oncology Research, Boehringer IngelheimThe inaugural European Protein Degradation Congress was the first of its kind to discuss how to translate protein degradation probes to safe effective therapeutics within Europe.In November, the series lands in Hong Kong - Protein Degradation Asia and once again will bring together leading industry players within big pharma and biotech along with expert academics in the ubiquitin space - providing an open forum and facilitate the sharing of in vitro and in vivo data, as well as build a deeper mechanistic understanding of the ubiquitin pathways and techniques to make the ‘undruggable’ druggable. Expect to hear strategies to overcome the structural biology, pharmacology and chemistry obstacles associated with the discovery and development of these bi-functional and single entity molecules.
 
Protein Engineering Congress
12-13 Nov 2019
Frankfurt, Germany
Most enzymes found in nature are not suitable for industrial purposes. The field of protein and enzyme engineering is growing at a rapid rate, with competition within industries high and the need to optimise performance greater than ever. Introducing the European Protein Engineering Congress, dedicated to uncovering the new and emerging practices, techniques and methods of protein and enzyme engineering across industries.With pharmaceutical, flavour & fragrance, consumer goods, animal feed, and agrochemical sectors all approaching the design, build and generation of new biocatalysts and molecules not found in nature, come and learn from our line-up of leading speakers to get an update on the new technologies used in the field of strain and protein engineering. Are you tasked with API and natural product synthesis? Why not hear how the industry is applying biosynthetic pathway transfer and multi-model assembly strategies to generate new molecules for industrial purposes? Are you struggling to craft new enzymes never-before-seen in this century? Hear how ancestral sequence reconstruction, smart-library design, and computer-aided innovation can allow you to discover and generate new and stable active enzymes.Attend and you'll be able to; increase your product pipeline, increase product efficiency and increase differentiation by meeting the experts in the biocatalysis and protein engineering space.This is not your average protein engineering congress...it's about industry, sharing knowledge and optimising your protein engineering method for the best outcomes.
 
Microbiome Congress 2019
13-14 Nov 2019
London, UK
The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.
 
20-21 Nov 2019
Boston, USA
The Vein-to-Vein Congress gathers manufacturing and supply chain heads from Biotechs, and pharmaceutical companies to address the industrialization and supply chain considerations that are being incorporated to facilitate commercial manufacture and delivery of cell therapies. The congress will discuss how to overcome the challenges including automation, storage, shipping and quality control. As the industry shifts from open and manual manufacturing to closed, automated and scalable systems the congress will discuss how to provide for greater product consistency, efficiency, and traceability throughout the process. With multiple steps and stakeholders in the process, the secret to a successful supply chain lies in mapping out the entire process and employing technology to mitigate risks. With case studies from across the oncology and autoimmune disease sectors, the Congress prepares you for a high production future.
 
29-30 Jan 2020
Washington D.C., USA
The inaugural Phage Futures Congress 2019 in Washington D.C was the first of its kind to discuss how to translate phage-based application in to clinically and commercially viable therapeutics.Join us in 2020 as we once again bring together over 250+ representatives from established biotech companies (from human and animal applications), new adopters, key academic researchers and big pharma. Expect to hear:Developments within phage applications across acute and chronic illnessesRegulatory discussions, including clinical trial landscape updatesUnderstanding of the animal health phage applications can translate into progressing human phage therapy commercialisation
 
CAR-T Congress EU 2020
29-30 Jan 2020
London, United Kingdom
CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. 2019 has seen yet another approval added to the list with NICE’s recommendation for Kymriah for diffuse large B-cell lymphoma. With emerging research to support the development of safe and efficacious CAR-Ts , the race is now on to lead the commercialization of accessible therapies.The European CAR-T congress is bringing together the leading pharmaceutical companies, the disruptive biotechs and pioneering academic institutions to assess emerging novel data and tackle the current challenges including antigen discovery, manufacturing scalability and efficacy in order to increase the uptake of CAR-T therapy.
 
CAR-T Congress USA 2020
29-30 Apr 2020
Boston, USA
The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.
 
European Protein Degradation Congress 2020
12-13 May 2020
Basel, Switzerland
“Targeted protein degradation promises to be the greatest innovation in small molecule drug discovery in the new millennium.” - Manfred Koegl, Lab Head Oncology Research, Boehringer IngelheimWith capital investment coming in fast, industry is ready to commercialise the therapeutic potential of PROTACs and molecular glues to build safe, effective targeted protein degradation products. As Arvinas conducts the groundbreaking first PROTAC clinical trials this year, it could be only be a matter of time before PROTACs and molecular glues enter the market. The European Protein Degradation Congress will bring together leading industry players within big pharma and biotech along with expert academics in the ubiquitin space - providing an open forum and facilitate the sharing of in vitro and in vivo data, as well as build a deeper mechanistic understanding of the ubiquitin pathways and techniques to make the ‘undruggable’ druggable.Expect to hear strategies to overcome the structural biology, pharmacology and chemistry obstacles associated with the discovery and development of these bi-functional and single entity molecules.
Filter by:
 
Personalized Nutrition 2019
26-27 Jun 2019
San Francisco, CA, USA
Hyperconnected and health-focused consumers are switching their purchasinghabits from a one-size-fits-all approach to personalized solutions, digital interfacesand on-demand manufacturing. The nutrition space is no exception. With increasingpopulations of ‘biohackers’ there is a demand to self quantify, pre-diagnose andconsume only foods designed to fit your daily macros. But how does the nutritionindustry provide for n=1?The Personalized Nutrition Innovation Summit showcases disruptive start ups infour main categories; biological data capture, data analysis, meal planning andsupplement providers.From personalized vitamins to AI-driven meal planning, we will be discussing how todevelop scalable, trackable and attainable personalized nutrition solutions.The summit brings together CEOs, CTOs, investors and founders across the nutritionindustry. Attend the summit to learn how to assess the current science behindpersonalized nutrition, the tools to strengthen recommendations and the steps tofoster partnerships in this multidisciplinary ecosystem.
 
Microbiome Invest 2019
23 May 2019
London
Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors and multinational nutrition and health companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
 
European Protein Degradation Congress
22-23 May 2019
Basel, Switzerland
“Targeted protein degradation promises to be the greatest innovation in small molecule drug discovery in the new millennium.” - Manfred Koegl, Lab Head Oncology Research, Boehringer IngelheimWith capital investment coming in fast, industry is ready to commercialise the therapeutic potential of PROTACs and molecular glues to build safe, effective targeted protein degradation products. As Arvinas conducts the groundbreaking first PROTAC clinical trials this year, it could be only be a matter of time before PROTACs and molecular glues enter the market. The European Protein Degradation Congress will bring together leading industry players within big pharma and biotech along with expert academics in the ubiquitin space - providing an open forum and facilitate the sharing of in vitro and in vivo data, as well as build a deeper mechanistic understanding of the ubiquitin pathways and techniques to make the ‘undruggable’ druggable.Expect to hear strategies to overcome the structural biology, pharmacology and chemistry obstacles associated with the discovery and development of these bi-functional and single entity molecules.
 
CAR-T Congress USA 2019
16-17 Apr 2019
Boston, USA
The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.
 
Human Biotech Animal Health 2019
9 Apr 2019
Hyatt Regency Boston Harbor, Boston, MA
Join the first ever conference connecting human biotechs with the animal health industry. Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.
 
20-21 Mar 2019
Boston, USA
Our speakers will explore ground-breaking developments surrounding CRISPR and utilising all genome editing tools as a therapy. It will focus on advancements to overcome ‘off targets’, delivery approaches for in vivo applications and efficacy considerations across patient diversity.CRISPR Therapeutics’ TJ Cradick and Cellectis’ Stefan Scherer will share their clinical trial experiences within therapeutic genome editing applicationsHarvard’s Richard Sherwood will share how to improve CRISPR safety by utilizing machine learningCasebia’s Abraham Scaria will offer delivery guidance to progress in vivo applicationsIn an extremely busy and exciting space it can be hard to pick out the top tool innovations to increase precision and properly discuss clinical challenges, this meeting will facilitate this. It will provide an opportunity with engage with the leading experts who are working on new platforms, leading the clinical trials and have patient insights. It is also a forum to build collaborations to create a clinically and commercially viable, effective and safe approach within gene and cell therapy medicine. ‘CRISPR medicines have the potential to transform the treatment for rare genetic and perhaps common diseases; the challenge for scientists is to demonstrate that these medicines can be both safe and effective’ – Steve Rees, VP of Discovery Biology, AstraZenecaSPEAKERS FROM 
 
CAR-T Congress EU 2019
30-31 Jan 2019
London, United Kingdom
CAR-T cell therapy has shown unparalleled success in haematological malignancies, paving the way for the field of immuno-oncology. In 2017 two therapies achieved FDA approval in the USA, and following recent approval by the EMA, it is a landmark time for the industry. Despite the huge successes there are still a number of hurdles to overcome before CAR-T can be effective in mainstream oncology beyond haematological malignancies. The European CAR-T Congress’ mission is to address the opportunities and challenges that presently face the CAR-T field, to maximise the potential of this ground-breaking therapy.Sessions include:Solid tumour targeting: overcoming the tumour microenvironmentMulti-specific & dual targeting CARsProcess development, scalability & automationAllogeneic vs Autologous: the potential of off-the-shelf therapiesPatient access, implementation & regulatory challengesAdvances in gene engineeringSafety and toxicity
 
29-30 Jan 2019
Washington DC, USA
The Phage Futures Congress will bring together peers from biotech companies and academia, along with experts from regulatory bodies, pharmaceutical companies and government institutions, to discuss how to actively progress clinical science and viable phage application routes to market. You will hear about:Regulatory guidance to achieve clinical data from Cara Fiore, FDAStrategies to access the market via the veterinary, personalized medicine and traditional pharmaceutical routesInsights into investment drivers for phage therapy from NIH and Boehringer IngelheimFacts on how to manufacture GMP phageApplications to overcome multi-drug resistance with combined approaches such as phage therapy and antibiotics "This congress has the potential to act as a catalyst to further cooperative and collaborative efforts to develop alternate Phage based approaches to the antibiotic crisis. In addition, the location in the Washington DC area will facilitate an opportunity for Government Agencies, responsible for public health, such as the NIH, FDA, USDA and DOD to participate and interact with educational research groups and biotechnology companies developing phage therapies and initiating clinical testing." - Carl Merril, Adaptive Phage Therapeutics
 
Personalised Nutrition Europe 2018
5-6 Dec 2018
London, UK
Personalised Nutrition Europe is dedicated to the innovators & disruptors in nutrition. Bringing together industry leaders with emerging companies & start-ups to discuss the potential of this growing field on public health. Meet the start-ups redefining diet, incorporating a wide range of analytics and technologies to provide insights into healthcare, and hear from global nutrition companies on how the technology revolution will impact the food industry & influence consumer trends.Personalised Nutrition Europe draws on industry leaders who discuss how to integrate existing and new types of data around health and disease to reveal informative and actionable insights. The Summit will teach you how to better acquire, understand and use your data to forge the key partnerships in this industry. Key Takaways:How can I scale up my product?How can I measure the performance of my nutritional intervention?How can I better target the consumer by understanding motivation behind nutrition choices?How can I partner with retailers and industry leaders?How do I use my data to forge partnerships in industry?How can I target my consumer better and ensure they adhere to nutritional plans?How to identify and incorporate the best science into my business?How can I produce high quality data with low cost testing?How can I improve my business strategy to capitalise on growing interest in personalisation?What policy changes do I need to consider to protect my business?
 
Microbiome Congress 2018
14-15 Nov 2018
London, UK
The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.
 
Personalized Nutrition Innovation Summit 2018
26-27 Jun 2018
San Francisco, CA, USA
The Personalized Nutrition Innovation Summit is dedicated to the innovators & disruptors in nutrition. Bringing together industry leaders with emerging companies & start-ups to discuss the potential of this growing field on public health. Meet the start-ups redefining diet incorporating a wide range of analytics and technologies to provide insights into healthcare, and hear from global nutrition companies on how the technology revolution will impact the food industry & influence consumer trends.5 key benefits of attending:• Enabling collaboration through dedicated networking sessions• Hear from the disruptors like Habit• Gain insight from major nutrition companies like Kellogg to understand their drivers• Understand from STYR Labs about making better babies through personalized nutrition and AI• Recognize the major consumer trends reshaping nutritionFeaturing breakthrough technologies, including:• Microbiome analytics• Genomics• Biomarkers• Biosensors & wearables• AI & Big data• Retail & eCommerce
 
Human Biotech Animal Health EU
18-19 Jun 2018
Amsterdam, The Netherlands
Join the first ever conference series connecting human biotechs with the animal health industry. Following the event's hugely successful launch in Boston, USA, Human Biotech & Animal Health Business Partnering Summit is now coming to Europe. Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.
 
Microbiome Invest 2018
23 May 2018
Novotel London West, London, UK
The Microbiome Invest Congress 2018 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
 
8-9 May 2018
Boston, USA
The influence of the microbiome on human health & disease has been a growing area of interest in recent years, however until recently the impact of the microbiome on the initiation, progression & treatment of cancer was unknown. In recent months research has uncovered the potential of the microbiome to improve cancer therapies and to be a useful tool for patient stratification and diagnostics. With a better understanding of the oncobiome there is the potential to improve patient outcomes and increase the efficacy of existing therapies and drugs.
 
CAR-T Congress USA
20-22 Mar 2018
Boston, USA
The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.
 
Human Biotech Animal Health Partnering
12-13 Mar 2018
Boston, USA
Join the first ever conference connecting human biotechs with the animal health industry. Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.
 
Artificial Intelligence: Transforming Pharma
21-22 Feb 2018
Boston, USA
The Artificial Intelligence: Transforming Pharma Congress will discuss AI's potential for more efficiently discovering medical trends and efficacious therapeutics and also for streamlining the development phase. We'll be sharing case studies and analysis into current AI partnerships and collaborations.
 
Combined CAR-T Congress 2018
30-31 Jan 2018
Berlin, Germany
CAR-T clinical trials have demonstrated unparalleled success achieving remission rates of up to 94% in multiple hematological malignancies…is CAR-T therapy what we’ve been waiting for?Join 18+ thought-leaders from biotech, big pharma, academia and the wider service community on 30th – 31st January 2018 at Europe’s first congress dedicated to addressing the challenges and opportunities of CAR-T therapies.Hear first-hand results from unpublished human and clinical studiesExplore the challenges of the tumour microenvironmentUnderstand how to implement a combined approach to cell therapyDiscover safety switch improvement strategiesNetwork with 100+ attendees to share knowledge and understand the commercial opportunities of CAR-TWith a 50:50 split of academia to industry, build relationships whilst being updated by 20+ amazing speakers from University Hospital of Cologne, Catapult, Cellectis and more on all of the latest developments in this exciting field. Get involved today.
 
3D Cell Models Congress
24-25 Jan 2018
Berlin, Germany
The 3D Cell Models Congress 2018 will present the latest developments and innovation in three-dimensional cell models including organoids, spheroids, and organ-on-a-chip, as well as bioprinting technologies.
 
European Microbiome Congress
27-29 Nov 2017
London, UK
The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.
 
Animal Health Asia 2017
18-19 Oct 2017
Grand Hyatt, Beijing, PRC
Animal Health Innovation Asia is the premier B2B conference showcasing innovative technologies within the livestock, aquaculture and companion animal health markets. Last year, over 160 senior-level executives and influencers joined us to engage with the industry and discuss financial investment, M&A and market access into Asia. Our 2017 event in Beijing had a special focus on China, with ten strategic partners from the region forming our Company Showcase - a chance for global companies to find new business partners from within China.
 
Market Access for Cell & Gene Therapy
18-19 Oct 2017
London, UK
With the increase in the number of cell and gene therapies being developed and coming to market globally and the potential to revolutionise the treatment of disease, this summit will discuss strategies for pricing and contracting cell or gene therapies that will allow payers to fund these innovative and significantly beneficial therapies to result in rapid patient access.
 
Aquaculture Innovation
27-28 Sep 2017
London, UK
The Aquaculture Innovation Summit is a new conference, as part of the Animal Health Innovation series, which focuses on showcasing and supporting innovation and sustainability initiatives in three key areas of aquaculture: farm management, nutrition and health.

Sponsorship Opportunities

At Kisaco Research we bring our clients both intensively researched conference programmes and the most influential networks. Kisaco Research genuinely helps its clients set and reset their business destinations and chart their own courses.

Benefits of Attending our Events

Meet industry peers that will help build a career-changing network for life.

MEET

industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes - ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

LEARN

from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

NOTE

down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest from the mistakes of your peers as much as their successes - ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

INVEST

both in your company growth and your own personal development by signing up to one of our events and get started.